Date and Time
Monday, May 22nd, 2017
2:00 PM - 3:00 PM CDT
MEMBERS: $100 per topic OR $250 for all 3 topics*
NON-MEMBERS: $200 per topic OR $600 for all 3 topics*
*By purchasing this webinar you will automatically be signed up for the follow-up discussion of the finalized rule change (Post discussion date TBD). Traditionally, comment periods will close and the agency will publish finalized rules within three months. We will contact you with the webinar link and date as soon as the finalized rules are published.
**The remaining two topics in the series will include proposed Medicare policy changes to Hospital Outpatient Services and Physicians. All three topics include a pre- and post-rule outcome discussion (with corresponding webinars) for a total of six webinars in this series.
Join us to review proposed Medicare policy changes that will impact Hospital Inpatient services and payments effective October 1, 2017. Our focus will be on the policy and payment changes that may have the greatest impact on medical devices and their related procedures.
Topics Covered Will Include
- Overview of Hospital Inpatient Prospective Payment System
- New/reclassified MS-DRGs (Medicare Severity Diagnosis Related Groups)
- MS-DRGs payment changes
- Payment changes for new technologies, including New Technology Add-on Payments (NTAP)
- Review of device credit policy
- Other significant policy changes impacting medical technology
- Public comment submission process
Presenters include Jolayne Devers (JD LYMON) and Mark Domyahn, MBA (Pursuance Consulting), who together have over 30 years of medical device related reimbursement experience. They have both successfully navigated policy and reimbursement changes for large and small companies, and bring their expertise and insight in analyzing the final changes published by Medicare.
Mark Domyahn, President & Founder, Pursuance Consulting
Mark Domyahn is President and Founder of Pursuance Consulting, a consulting firm focused on strategic reimbursement and health economics consulting for medical device companies. Mark has spent his entire career in health care, and has focused the last 15 years on developing and implementing reimbursement strategies and economic tools for medical technologies across multiple specialty areas including cardiology, orthopedics and neurostimulation. He has a track record of success, including acquiring incremental payment from CMS for several technologies, securing new CPT and ICD-9/10 procedure codes and successfully navigating coverage with various payers. Mark also has extensive experience in health policy, interpreting policy implications for medical technology and integrating them into business strategies.
Mark most recently was with St. Jude Medical (now Abbott) as Senior Director, Global Healthcare Economics. In that role, Mark coordinated healthcare economics and reimbursement activities globally across the entire St. Jude Medical product portfolio. He has served in similar leadership roles in various other medical device companies, including Zimmer, CardioMEMS, Restore Medical and Medtronic.
Mark holds a Masters of Business Administration from the Wharton School, and a Bachelor of Science from Minnesota State University-Moorhead.
Jolayne Devers, Principal, JD LYMON Group
For over 25 years, Jolayne has worked in the health care industry years in a variety of sectors, including a world-leading medical device company, a large commercial payer, and a provider organization. As a certified coder, she has used this broad experience to build unique expertise in medical device and drug optimization strategies for product reimbursement and market access. Her biggest success stories involve developing a customized reimbursement approach that aligns with the overall business plan and effectively integrates with clinical, regulatory, sales and marketing.
As a consultant and Certified Professional Coder (CPC, COC, CPC-H, CPC-P), she has successfully established numerous government payment mechanisms for MS-DRGs, APCs and RVUs in addition to obtaining CPT, ICD-9-CM and HCPCS codes for emerging technologies in the medical device, pharmaceutical and biotechnology industries. Jolayne currently provides CPT, RUC and strategic consulting to the American Society of General Surgery to guide them on the political and economic changes that affect general surgeons and the quality care they provide for their patients.
Jolayne holds a BS from the College of St. Catherine and a Master’s degree in Business Administration from the University of St. Thomas.
Other events in this series:
Join us to review Medicare policy changes for Physician services and payments, in calendar year 2018. Our focus will be on the policy and payment changes that may have the greatest impact on medical devices and their related procedures.
Join us to review Medicare policy changes that for Hospital Outpatient and Ambulatory Surgery Center (ASC) services and payments in calendar year 2018. Our focus will be on the policy and payment changes that may have the greatest impact on medical devices and their related procedures.